UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~January 12,~~May 10, 2010

Date of Report – (Date of earliest event reported)

CHEM RX CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	000-51518	20-2938469
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

750 Park Place

Long Beach, New York 11561

(Address of principal executive office, including zip code)

(516) 889-8770

(Registrant’s telephone number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 51.0203 – ~~Departure~~Bankruptcy ~~of Directors~~ or ~~Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Receivership.

~~(b)~~ On ~~January~~ 12May 11, 2010, J.Chem ~~Jay~~Rx ~~Lobell~~Corporation (“Chem Rx”) and ~~David~~its direct and indirect subsidiaries B.J.K. ~~Kellman~~Inc., ~~resigned~~ChemRx ~~from~~New ~~the~~Jersey, ~~board~~LLC, ofChemRx/Salerno’s, LLC, ~~directors~~ChemRx-Boca ofRaton, LLC and ChemRx Care, LLC (collectively with Chem Rx, ~~Corporation~~the “Debtors”) filed voluntary petitions for relief under chapter 11 of the United States Bankruptcy Code (the “~~Chem~~Bankruptcy RxCode”), in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) (Case Nos 10-11567 through 10-11572). The Debtors continue to operate their business as “debtors-in-possession” under the jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and orders of the Bankruptcy Court.

~~(d) On~~Item ~~January~~2.04 ~~15,~~– ~~2010,~~Triggering ~~Gary~~Events M.That ~~Jacobs~~Accelerate ~~and~~or ~~Evan~~Increase ~~Selzer~~a ~~were~~Direct ~~appointed~~Financial Obligation ~~directors~~or ~~of Chem~~an RxObligation under an Off-Balance Sheet Arrangement.

~~Gary~~On ~~M. Jacobs is the Chief~~May ~~Financial Officer of Chem Rx. He became Chief Financial Officer of Chem Rx on June 12~~10, ~~2008. From May 2005 to June 2008~~2010, ~~Mr. Jacobs was~~ the ~~Chief Financial~~administrative ~~Officer~~agent ~~and~~under ~~Chief~~Chem ~~Operating~~Rx’s ~~Officer~~First ofLien ~~Gold~~Credit ~~Force International, Ltd., a supplier of gold, silver~~ and ~~pearl jewelry to U.S. retail chains, and Karat~~ ~~Platinum~~Guaranty ~~LLC~~Agreement, adated ~~developer~~as of anOctober ~~alternative to platinum. From July 2003 to April 2005~~26, ~~Mr. Jacobs~~2007 ~~served~~ (as ~~President of The Innovative Companies~~amended, ~~LLC~~supplemented, a ~~supplier~~restated ofor ~~natural~~otherwise ~~stone. From~~modified ~~October~~through ~~2001~~the todate ~~February 2003~~hereof, ~~Mr. Jacobs~~ ~~served~~the as“Credit ~~Executive Vice President of Operations and Corporate~~Agreement”), ~~Secretary~~delivered ofto ~~The~~Chem ~~Hain~~Rx ~~Celestial Group, Inc.,~~ a ~~food~~notice ~~and personal care products company. Mr. Jacobs also served as Executive Vice President~~ of ~~Finance, Chief~~acceleration ~~Financial~~which ~~Officer~~under ~~and~~the ~~Treasurer~~terms of ~~The Hain Celestial Group, Inc. from~~the ~~September~~Credit ~~1998~~Agreement to(a) ~~October~~terminated ~~2001.~~the ~~Prior~~commitments ~~to that~~thereunder, ~~Mr. Jacobs~~and ~~was~~(b) ~~the~~made ~~Chief~~the ~~Financial~~entire ~~Officer~~principal amount of ~~Graham~~the ~~Field~~loans ~~Health Products~~outstanding, ~~Inc.,~~together awith ~~manufacturing~~accrued ~~and~~interest ~~distribution~~thereon ~~company.~~and ~~Mr. Jacobs~~all ~~was~~fees ~~employed~~and ~~for~~other 13obligations ~~years~~accrued asunder athe ~~member~~Credit ofAgreement ~~the~~and ~~audit~~certain ~~staff~~other ofloan ~~Ernst & Young LLP~~documents, ~~where~~equal heto ~~attained~~an ~~the~~alleged ~~position~~aggregate of approximately ~~senior~~$103,000,000, ~~manager. He~~immediately isdue ~~a certified public accountant~~ and ~~holds a Bachelor’s of Business Administration in Accounting from Adelphi University~~payable.

~~Evan Selzer is currently an~~The ~~Executive~~ability ~~Vice~~of ~~President~~the creditors of ~~Chem~~the ~~Rx. Mr.~~Debtors ~~Selzer~~to ~~has~~exercise ~~been~~remedies ~~employed~~to byenforce their ~~Chem~~rights Rxagainst ~~since~~the ~~March~~Debtors ~~1989~~under inthe ~~various~~debt ~~senior~~instruments ~~management~~and ~~positions~~other ~~including~~agreements ~~Director~~described ofabove ~~Purchasing~~is ~~and~~automatically ~~Vice~~stayed ~~President. His~~as ~~breadth~~a result of ~~experience includes~~the ~~all~~filing ~~operations~~ of ~~Chem Rx~~the Debtors’s ~~pharmacy,~~chapter ~~stock~~11 cases, ~~delivery~~ and ~~purchasing departments. Mr.~~the ~~Selzer~~creditors’s ~~current~~rights ~~responsibilities~~of ~~include~~enforcement ~~product~~are subject ~~purchasing,~~to ~~new~~the ~~technology~~applicable ~~and~~provisions ~~general~~of ~~operations~~the Bankruptcy Code.

Item 8.01 – Other Events.

On May 11, 2010, Chem Rx issued a press release describing the Debtors’ chapter 11 filing. The press release is incorporated as Exhibit 99.1.

Item 9.01 – Financial Statements and Exhibits.

Number		Description

99.1		Press Release dated May 11, 2010

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CHEM RX CORPORATION

	CHEM RX CORPORATION

Dated: May 12, 2010	By:	/s/ Gary M. Jacobs
		Name: Gary M. Jacobs
		Title: Chief Financial Officer

Dated: January 19, 2010	By:	/s/ Steven Silva
		Name: Steven Silva
		Title: President and Chief Operating Officer

EXHIBIT INDEX

Number		Description

99.1		Press Release dated May 11, 2010

Filing Compare · CHEM RX CORP